| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Nbvm Gp, LLC is a 10% Owner at LYRA. Recent filings cover 9 purchases and 3 sales. Those positions are worth an estimated $6.1M at current prices.
Nbvm Gp, LLC's largest disclosed position is in LYRA as 10% Owner, worth about $6.1M. Net of sales, the recent Form 4 record there shows accumulation of 4,400,900 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Buy | 1,805,416 | $2.43 | $4,387,160.88 | +252.0% | +32.7% | -87.1% | |
| Apr 12, 2022 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Buy | 2,369,667 | $4.22 | $9,999,994.74 | -225.4% | -1.8% | -59.5% | |
| May 5, 2020 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Sell | 24,183 | $16.00 | $386,928.00 | -4.8% | - | - | |
| May 5, 2020 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +82.5% | - | - |